These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28533390)
1. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia. Papaioannou D; Shen C; Nicolet D; McNeil B; Bill M; Karunasiri M; Burke MH; Ozer HG; Yilmaz SA; Zitzer N; Behbehani GK; Oakes CC; Steiner DJ; Marcucci G; Powell BL; Kolitz JE; Carter TH; Wang ES; Mrózek K; Croce CM; Caligiuri MA; Bloomfield CD; Garzon R; Dorrance AM Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4641-E4647. PubMed ID: 28533390 [TBL] [Abstract][Full Text] [Related]
2. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia. Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772 [TBL] [Abstract][Full Text] [Related]
3. High Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Qian T; Quan L; Cui W; Pan Y; Ye X; Shi J; Fu L Cancer Biol Ther; 2019; 20(10):1314-1318. PubMed ID: 31306053 [TBL] [Abstract][Full Text] [Related]
4. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels. Glenjen NI; Hatfield K; Bruserud Ø Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103 [TBL] [Abstract][Full Text] [Related]
5. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients. Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia. Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma. Goda C; Kolovich S; Rudich A; Karunasiri M; Kulkarni R; Rajgolikar G; Neidemire-Colley L; Singh S; Sircar A; Ranganathan P; Garzon R; Sehgal L; Dorrance AM Exp Hematol; 2023 Jul; 123():28-33.e3. PubMed ID: 37209901 [TBL] [Abstract][Full Text] [Related]
11. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma. Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284 [TBL] [Abstract][Full Text] [Related]
13. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392 [TBL] [Abstract][Full Text] [Related]
14. Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients. Marcel V; Catez F; Berger CM; Perrial E; Plesa A; Thomas X; Mattei E; Hayette S; Saintigny P; Bouvet P; Diaz JJ; Dumontet C PLoS One; 2017; 12(1):e0170160. PubMed ID: 28103300 [TBL] [Abstract][Full Text] [Related]
15. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia. Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469 [TBL] [Abstract][Full Text] [Related]
16. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia. Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222 [TBL] [Abstract][Full Text] [Related]
17. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia. Wang N; Guo D; Zhao YY; Dong CY; Liu XY; Yang BX; Wang SW; Wang L; Liu QG; Ren Q; Lin YM; Ma XT Oncotarget; 2015 Aug; 6(25):20977-92. PubMed ID: 26023795 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia. Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia. Wang J; Yu M; Guo Q; Ma Q; Hu C; Ma Z; Yin X; Li X; Wang Y; Pan H; Wang D; Huang J; Meng H; Tong H; Qian W; Jin J Sci Rep; 2017 Apr; 7():45960. PubMed ID: 28452374 [TBL] [Abstract][Full Text] [Related]
20. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]